Search Results

Risperidone has low risk of EP symptoms.

Subjects: *RISPERIDONE; *ANTIPARKINSONIAN agents; *EXTRAPYRAMIDAL disorders

• Source: Brown University Psychopharmacology Update. Aug97, Vol. 8 Issue 8, p3. 2p.

Record details

Olanzapine Vs. Haloperidol Study Schizophrenia treatment: Should conventional antipsychotics be shelved in favor of newer agents?

Subjects: OLANZAPINE; SCHIZOPHRENIA treatment; ANTIPSYCHOTIC agents

• Source: Brown University Psychopharmacology Update; Feb2004, Vol. 15 Issue 2, p1-7, 4p

Record details

Updated PORT psychopharmacological treatment recommendations.

Subjects: SCHIZOPHRENIA treatment; HEALTH outcome assessment; PEOPLE with schizophrenia

• Source: Brown University Psychopharmacology Update; Apr2010, Vol. 21 Issue 4, p1-7, 3p

Record details

EMSAM offers hope -- without some of the dietary restrictions -- for long-term treatment of depression.

Subjects: SELEGILINE; THERAPEUTICS; MENTAL depression

• Source: Brown University Psychopharmacology Update; Feb2007, Vol. 18 Issue 2, p1-6, 3p

Record details

Stakeholders' perspective on modalities to reduce anticholinergic burden.

Subjects: PARASYMPATHOMIMETIC agents; DRUG prescribing; DRUG interactions

• Source: Brown University Psychopharmacology Update; Feb2022, Vol. 33 Issue 2, p2-3, 2p

Record details

Anticholinergic drugs and measures of cognitive impairment.

• Authors : Lam, Y. W. Francis

Subjects: COGNITION disorders in old age; DRUG interactions; DRUG side effects

• Source: Brown University Psychopharmacology Update; Nov2019, Vol. 30 Issue 11, p2-3, 2p

Record details

Newly approved asenapine promising for acute episodes of schizophrenia.

Subjects: SCHIZOPHRENIA treatment; HALOPERIDOL; CLINICAL drug trials

• Source: Brown University Psychopharmacology Update; Jul2010, Vol. 21 Issue 7, p1-6, 3p

Record details

Mood stabilizer equal to combination treatment for acute bipolar depression.

Subjects: MOOD stabilizers; BIPOLAR disorder; THERAPEUTICS

• Source: Brown University Psychopharmacology Update; Jul2010, Vol. 21 Issue 7, p1-7, 3p

Record details

Study shows antipsychotic polypharmacy continues to be widespread.

• Authors : Faries, D.; Ascher-Svanum, H.; Zhu, B.

Subjects: ANTIPSYCHOTIC agents; PEOPLE with schizophrenia; PSYCHOSESELI Lilly & Co.FARIES, Douglas

• Source: Brown University Psychopharmacology Update; Oct2005, Vol. 16 Issue 10, p1-7, 3p

Record details